Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma

NCT02920697 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukaemia (CLL)
B-Cell Non-Hodgkin Lymphoma (NHL)
Multiple Myeloma (MM)

Interventions

DRUG: S 55746

Sponsor

Institut de Recherches Internationales Servier

Collaborators

[object Object]